Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Turki Mohammad Noor Al-Sulaimani"'
Autor:
Abdul Haseeb, Hani Saleh Faidah, Manal Al-Gethamy, Muhammad Shahid Iqbal, Abrar Mohammed Barnawi, Shuruq S. Elahe, Duha Nabeel Bukhari, Turki Mohammad Noor Al-Sulaimani, Mohammad Fadaaq, Saad Alghamdi, Waleed Hassan Almalki, Zikria Saleem, Mahmoud Essam Elrggal, Amer Hayat Khan, Mohammed A Algarni, Sami S. Ashgar, Mohamed Azmi Hassali
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Background: Antimicrobial stewardship programs (ASPs) are collaborative efforts to optimize antimicrobial use in healthcare institutions through evidence-based quality improvement strategies. With regard to critically ill patients, appropriate antimi
Externí odkaz:
https://doaj.org/article/7bdc635dc2e840ad8451b7b083507c97
Autor:
Nisrin Nasseraldeen Bifari, Abdul Haseeb, Dina Jameel Ridnah, Ghadair Al-Nass, Arwa Saleh Alzahrani, Shaza Eid O. Alharbi, Turki Mohammad Noor Al-Sulaimani, Weam Waiel Kutob, Muhammad Shahid Iqbal, Eman Abdullah Alzhrani, Mohamed Fadaq, Samah Mohammed Bugis
Publikováno v:
Journal of Pharmaceutical Research International. :20-27
Introduction: During Hajj and Umrah season, asthma-related acute admissions produce the enormous burden on healthcare facilities and causes delay in admissions for more severe cases, e.g. myocardial infarction, cardiac failure and severe trauma cases
Autor:
Turki Mohammad Noor Al-Sulaimani, Mohammed A. Algarni, Saad Alghamdi, Mahmoud E Elrggal, Amer Hayat Khan, Hani S. Faidah, Duha Nabeel Bukhari, Shuruq Sami Elahe, Sami S. Ashgar, Mohamed Azmi Hassali, Waleed H. Almalki, Manal Al-Gethamy, Mohammad Fadaaq, Muhammad Shahid Iqbal, Zikria Saleem, Abrar Mohammed Barnawi, Abdul Haseeb
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 11 (2021)
Frontiers in Pharmacology, Vol 11 (2021)
Background: Antimicrobial stewardship programs (ASPs) are collaborative efforts to optimize antimicrobial use in healthcare institutions through evidence-based quality improvement strategies. With regard to critically ill patients, appropriate antimi